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ABSTRACT
EGFR amplification in cells having double minute chromosomes (DM) is commonly 
found in glioblastoma multiforme (GBM); however, how much it contributes to the 
current failure to treat GBM successfully is unknown. We studied two syngeneic 
primary cultures derived from a GBM with and without cells carrying DM, for their 
differential molecular and metabolic profiles, in vivo growth patterns, and responses 
to irradiation (IR). Each cell line has a distinct molecular profile consistent with an 
invasive “go” (with DM) or angiogenic “grow” phenotype (without DM) demonstrated 
in vitro and in intracranial xenograft models. Cells with DM were relatively radio-
resistant and used higher glycolytic respiration and lower oxidative phosphorylation 
in comparison to cells without them. The DM-containing cell was able to restore 
tumor heterogeneity by mis-segregation of the DM-chromosomes, giving rise to cell 
subpopulations without them. As a response to IR, DM-containing cells switched 
their respiration from glycolic metabolism to oxidative phosphorylation and shifted 
molecular profiles towards that of cells without DM. Irradiated cells with DM showed 
the capacity to alter their extracellular microenvironment to not only promote 
invasiveness of the surrounding cells, regardless of DM status, but also to create a pro-
angiogenic tumor microenvironment. IR of cells without DM was found primarily to 
increase extracellular MMP2 activity. Overall, our data suggest that the DM-containing 
cells of GBM are responsible for tumor recurrence due to their high invasiveness and 
radio-resistance and the mis-segregation of their DM chromosomes, to give rise to 
fast-growing cells lacking DM chromosomes.
INTRODUCTION
Glioblastoma multiforme (GBM) is one of the most 
aggressive forms of brain cancer and characteristically 
recurs despite treatment with post-operative radiation and 
chemotherapy. Overall survival of patients has been shown 
to depend on the specific molecular GBM subtype, with 
proneural and neural subtypes showing poorest response 
to conventional therapeutic intervention, while classical 
and mesenchymal subtypes exhibit statistically significant, 
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albeit quantitatively marginal, improvements in survival 
through extensive tumor resection and chemo/radiation 
therapies [1]. Intra-tumoral heterogeneity is a hallmark 
of GBM where the “M” stands for “multiforme”, and 
where subpopulations of cells can be distinguished based 
on their phenotypic resemblance to neuronal-glial stem 
cells. Subpopulations that exhibit properties similar to 
neuronal-glial stem cells and tumor-initiating capabilities, 
referred to as stem-like tumor initiating cells (STIC), 
differ from the majority of cells forming the tumor mass, 
referred to as tumor mass-forming cells (TMC). Each 
tumor subpopulation possesses different genetic and/or 
epigenetic abnormalities and has molecular phenotypes 
that impact a variety of tumorigenic behaviors. In 
GBM, STIC were shown to participate directly in tumor 
vascularization [2, 3].
Significant evidence points to the intra-tumoral 
heterogeneity of GBM as a major confounding factor for 
therapy, as plasticity of the subpopulation phenotypes, 
driven by evolving selective pressures within the tumor 
microenvironment, promote treatment resistance and 
tumor recurrence. This is supported by much of our past 
work demonstrating that clinically relevant irradiation (IR) 
paradigms were associated with increased oxidative stress, 
radio-resistance, cellular reprogramming and invasive 
behavior, of which the latter could be mediated by radiation-
induced macrovesicles [4, 5]. Similarly, work by ourselves 
and others has also substantiated the importance of EGFR 
amplification in GBM, either as chromosomal 7 polysomy 
or as double minute chromosomes (DMs) [6, 7]. However, 
EGFR amplification was not predictive of survival in 
glioma treated with an inhibitor of EGFR concurrently with 
chemo and radiation therapy [8], and supporting evidence 
is limited for the role of EGFR-encoding DM in GBM 
recurrence following frontline radiotherapy.
To further understand the mechanisms of GBM 
recurrence and the role that EGFR amplification plays in 
this process, we conducted studies using two syngeneic 
primary cultures of a likely classical GBM subtype. 
Each of these carefully characterized primary cultures 
expresses wild-type/functional proteins of TP53, PTEN, 
IDH1, and IDH2, but differed in regard to the presence 
(cell line 51A) or absence (cell line 51B) of DM, and gene/
protein expression patterns. Here we provide evidence in 
support of a GBM tumor recurrence mechanism dependent 
on tumor heterogeneity and favored by tumor-specific 
chromosomes, herein EGFR-encoding DMs.
RESULTS
Characterization of EGFR status in syngeneic 
primary cultures of a GBM
The primary human cultures established under 
neural sphere (NS) or serum adherent (SA) culture 
conditions, as depicted in Figure 1A, were derived from 
a recurrent GBM patient (G43) 14 months after initial 
resection followed by Temozolomide and radiotherapy 
(standard of care), and Avastin and Velcade (second line 
salvage therapies). Mutation assays showed wild-type 
sequences for PTEN, TP53, IDH1 and IDH2 genes in the 
original tumor and the two syngeneic primary cultures 
(51A and 51B).
Analysis of G43 DNA by comparative quantitative 
(CQ-) PCR indicated a 54-fold higher amplification of the 
EGFR gene compared to a standard reference gene [6]. As 
shown in Figure 1B-1C, fluorescence in situ hybridization 
(FISH) revealed EGFR-bearing DMs in cells that were 
maintained and slightly enriched (from 71% to 77%) 
in NS-culture; however, these were completely lost in 
SA-culture after 8 passages (Figure 1D). CQ-PCR also 
showed copy number variation of EGFR, normalized 
to the reference gene SPAG16, in the original tumor 
and derived cultures at various passages (Figure 1E). In 
contrast to similar variations of Chr7 (Figure 1D and 1F), 
EGFR copy score showed a high level of EGFR gene 
amplification in 51A and its clonal line 51AS7, but not 
in 51B or the other two clonal lines of 51A (51AS3 and 
51AS5), which originated from soft-agar colonies (Figure 
1A). A decrease in EGFR copy score was seen in 51AS3 
and 51B after many passages. This may be associated with 
a decrease of chromosome 7 score, which was observed 
directly in 51B (Figure 1F).
Restoration of tumor heterogeneity by mis-
segregations of Chr7 and DM
In the procedure of soft-agar-mediated cloning 
(Figure 1A), clonal cell lines were established from 51A 
(51AS3, 51AS5, 51AS7), but not from 51B. Both FISH 
and CQ-PCR consistently showed an EGFR-DM cell 
origin of 51AS7; however, the percentage (29%) of cells 
with DM was much lower than that in the parental culture 
(77%). In contrast, the equilibrium of tumor heterogeneity 
of Chr7, and Chr7 copy score, were similar between the 
clonal line (51AS7) and two initial primary cultures (51A 
p0 and 51B p0) (Figure 1D, 1F). Hence, DM cells were 
able to re-colonize and restore tumor heterogeneity by 
mis-segregations of Chr7 and DM, and DM-heterogeneity 
was likely related to tumor-specific phenotypes, as proven 
below, by comparative analyses of two GBM syngeneic 
primary cultures, with and without cells carrying DM.
Molecular profiles of cells with or without DM
A primary culture (51A) and clonal derivatives 
with or without DM (51AS3, 51AS5, 51AS7) cultured 
under NS conditions exhibit equivalent high level of full-
length (175 kD) EGFR, as determined by immunoblotting 
analysis. In contrast, a primary culture (51B) maintained 
under SA-conditions demonstrated consistently low levels 
of EGFR (Figure 2A). Cells cultured under both NS and 
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SA-conditions expressed wild-type (55 kD) PTEN, with 
NS-cultures (51A, 51AS3, 51AS5, 51AS7) exhibiting 
significantly higher PTEN expression than the SA-culture 
(51B). In addition, all EGFR-overexpressing NS-cultures 
(except 51AS5) showed high levels of NOTCH1 and 
γ-secretases (NCSTN and PSEN1) of NOTCH signaling 
(Figure 2A, right panel).
A high level of proteins in the NOTCH signaling 
pathway and GFAP was commonly seen in both neuronal-
glial stem/precursor and glioma stem-like cells [9], which 
is consistent with the neural stem cell phenotype of cells 
expected for NS-cultures of GBM. On the other hand, 
SA-cultures of 51B showed high expression of the early 
neuronal differentiation marker PAX6, which was rarely 
expressed by any of the NS-cultures (Figure 2A, left 
panel). Hence, there were two principal protein profiles 
that characterized the two key cell subpopulations of 
this GBM; PAX6low/EGFR-PTEN-NOTCHhigh (51A, NS-
culture), and PAX6high/EGFR-PTEN-NOTCHlow (51B, 
SA-culture). All clonal NS-subculture lines with (51AS7) 
or without (51AS3 and 51AS5) DM showed the same 
protein profile of PAX6low/EGFR-PTEN-NOTCHhigh as 
their parental NS-culture line 51A with DM.
We then used a neural stem cell differentiation 
assay to verify the neural stem cell feature of 51A 
suggested by its neurosphere phenotype and neural 
stem-cell marker expression. As shown in Figure 2B, 
immunocytofluorescence analysis showed expression 
of CD133, a common marker of glioma stem cells, by 
51A under non-differentiation culture conditions, which 
was diminished following 1-week of culture under 
differentiation conditions. Expressions of neuronal 
markers (MAP2 and TUBB3), which had low or 
undetectable expression prior to differentiation were 
increased/detected following differentiation. Decrease of 
CD133 and increase of MAP2 and TUBB3 expressions 
under differentiation conditions are characteristic features 
of neuronal precursor cells. Different from neuronal 
precursor, 51A expressed both NES and GFAP under both 
non-differentiation and differentiation conditions.
In order to delineate the different roles of tumor cell 
subpopulations in tumor recurrence after radiation, we 
Figure 1: NS-culture conditions maintained and enriched the GBM cell subpopulation carrying EGFR-encoding double 
minute chromosomes (DM). (A) depiction of the establishment of 51A and 51B primary cultures and their clonal lines expanded from 
single colonies formed in 0.3% soft agar. (B) representative microscope images of cell cultures (upper) and FISH (bottom). (C) a metaphase 
image of FISH of 51A showing near diploid nucleus with nearly forty copies of the EGFR double minute chromosomes, EGFR-encoding 
Chr7 is shown by an arrow, and the EGFR-deleted Chr7 by an arrowhead. (D) Chr7-copy number defined cell subpopulation equilibrium in 
the G43 tumor and its derived cell lines after various numbers of cell passages (p). The data were calculated based on more than 250 cells, 
with percentage of DM cells shown above the bar for the Chr7-cell populations. DM cells are shown in FISH images of the G43 tumor, 
but not counted (n/c). (E) EGFR gene copy score computed as ratios between EGFR and reference gene SPAG16 DNA copy numbers, 
determined by real-time comparative quantification (CQ-) PCR and normalized to human leukocyte DNA, which was set to unity. (F) Chr7 
copy score computed based on the average number of FISH-detected copies per cell.
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Figure 2: Differential molecular profiles and phenotypic behaviors of GBM cell subpopulations with and without 
DM. (A) immunoblotting whole cell lysates of primary cultures (51A and 51B) and clonal lines of 51A (51AS3, 51AS5, and 51AS7). Cell 
passages are shown within parentheses. (B) immunocytofluorescence analysis of monolayer cultures of 51A before and after a 7-day culture 
under neural stem cell differentiation conditions. (C) comparison of gene expressions between 51A and 51B, quantified by real-time qRT-
PCR, normalized to ACTB. Error bars represent SEM derived from 3 replicates.
Oncotarget80857www.impactjournals.com/oncotarget
applied the absolute quantitative reverse transcription PCR 
(AqRT-PCR) to measure the absolute ratio of a marker 
gene to an internal control gene (here ACTB) [10] and 
compared their differential expression in 51A and 51B. 
Marker genes were selected that encoded proteins with 
functions in early central nervous system development 
(NANOG, POU3F2, POU5F1, PAX6, PTEN, PDGFRA, 
and SALL2), matrix re-modeling, cell mobility and 
invasion (EFEMP1, AGAP2, CTSB, EPHA2, FOXM1, 
MMP2, MMP9, PLAU, PTK2, RHOC, SPARC, and 
TNC), tumor vascularization (ANGPT1, ANGPT2, FLIT1, 
NRP1, KDR, VEGFA, and PTN), DNA repair and cell 
survival (BIRC2, BIRC3, BIRC5, PRKDC, TXNRD1, 
XRCC5, and XRCC6), redox metabolism (CAT, GPX4, 
and SOD1), and glioma radioresistance (CHI3L1). As 
shown in Figure 2C, consistent with NS-culture-derived 
glioma cells with high invasiveness (Figure 3), genes 
highly expressed in 51A were those encoding markers of 
neural stem/precursor cells (NANOG, POU3F2, POU5F1, 
and SALL2), and pro-invasive proteins (AGAP2, EPHA2, 
FOXM1, PDGFRA, and TNC). In contrast, genes 
encoding angiogenic factors (ANGPT1, ANGPT2) and 
receptors (NRP1, and KDR) were highly expressed in 
SA-culture-derived glioma cells of 51B. Expression of 
MMP9 and FLIT1 was not detected, and expression of the 
angiogenic factor VEGFA was not differentially expressed 
between the two syngeneic glioma primary cultures.
“Go” or “grow” functional dependence on DM
Both AqRT-PCR and gelatin zymography assays 
confirmed the absence of MMP9 in 51A and 51B, but 
MMP2 was highly expressed, secreted, and activated in 
the extracellular compartment of 51B, in comparison to 
that of 51A (Figure 3A). We then examined tumor cell 
invasiveness by a matrigel invasion assay that was used 
to show MMP2-dependent invasion of glioma cell line 
U251 [11]. As shown in Figure 3B, the high level of 
active MMP2 in the extracellular compartment of 51B 
did not translate into high cell invasiveness, as compared 
to 51A and 51AS7, despite high expression of genes 
(CTSB, EFEMP1, PLAU, and SPARC) with pro-invasive 
properties. However, the level of invasiveness was 
positively related to the percentage of DM cells, which 
may be due to enhanced expression of another set of pro-
invasive genes, including those (AGAP2, PDGFRA, TNC, 
and FOXM1) in 51A, as shown in Figure 2C.
To examine the impact of the different phenotypes 
of 51A and 51B cells, suggested by their distinct molecular 
profiles, on their roles in tumor formation, we carried out 
intracranial (i.c.) implantation of defined mixtures of 
51A and 51B, each having previously been transduced 
with lentiviral vectors to express green (GFP) or red 
(RFP) fluorescence proteins, respectively. Keeping the 
total implanted cell number constant, the tumorigenicity 
of 51A-GFP and 51B-RFP cells was followed after 
implanting each line alone or in various proportions into 
the right hemispheres of nude mouse brains. All mice 
were followed to ethical end-points and their brain tissues 
were cryo-sectioned and observed under a fluorescence 
microscope following nuclear staining with DAPI.
Consistent with the result of the matrigel invasion 
assay, 51A cells were highly invasive in vivo. As shown in 
Figure 3C, a diffused tumor cell distribution throughout the 
mouse brain was observed in xenografts derived from i.c. 
implantation of 51A-GFP cells. In contrast, 51B-RFP cells 
formed large clusters of tumor masses, even when started 
as the minority (10%) of cells mixed with a majority 
(90%) of 51A-GFP cells, indicating the tumor-mass-
forming feature of 51B cells (Figure 3D). In xenografts 
derived from such proportion of mixing, the percentage of 
51A-GFP cells was calculated using the software provided 
with a Keyence BZ-X700 fluorescence microscope, which 
captured areas of green signals within the tumor mass 
and areas of green signals outside the tumor mass, which 
was readily marked by the red fluorescence signal from 
51B-FRP cells. The counts and size (μm2) of the total 
green areas vs the total green inside the tumor mass are 
77 and 13403 vs 43 and 10211, with area averages (SD) as 
174 (374) vs 237 (481), respectively. Based on count, 44% 
51A-GFP cells were outside the tumor mass, while based 
on area, it was 24%. The greater variations on area average 
but larger overall area within the tumor mass compared to 
those of the total green areas suggest a smaller and more 
uniform morphology of 51A-GFP cells outside the tumor 
mass.
Consistently, mice implanted with a majority 
(100%, 99% or 90%) of 51A cells (groups 1-3) versus 
a majority (100%, 99% or 90%) of 51B cells (groups 
4-6) showed significantly longer survival as revealed by 
Kaplan-Meier curves. In other words, adding as little as 
1% of 51B cells to 51A cells in the inoculum significantly 
shortened the survival time of mice (P < 0.001 in the 
comparison between groups 1 and 2) (Figure 3E). Thus, 
the highly invasive 51A cells had a lower level of i.c. 
tumorigenicity than the 51B cells, the latter having an 
angiogenic molecular profile in vitro (Figure 2B) and a 
local proliferation phenotype in vivo (Figure 3D).
To determine the differential growth speed of each 
cell subpopulation in vivo, we extracted DNA from the 
right hemisphere of each mouse’s brain in which the pre-
mixed 51A-GFP and 51B-RFP cells had been implanted 
and developed into a tumor, and performed CQ-PCR 
to quantify the copy numbers of GFP, RFP, EGFR and 
SPAG16 on DNA of 3-4 mice per group. As shown Figure 
3F, the level of EGFR amplification in the 51A-derived 
xenograft was similar to that of its parental clinical tumor, 
confirming the STIC nature of EGFR-DM containing 
cells. The DNA encoding GFP can be detected by CQ-
PCR in 51A-GFP derived xenografts, and its frequency is 
comparable to SPAG16 (ratio = 0.7). In xenografts derived 
from the mixture of 99% 51A-GFP and 1% 51B-RFP, 
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the ratio was dramatically decreased to 0.1, and was 
undetectable in xenografts from mixtures with a higher 
proportion of 51B-RFP cells. This demonstrated the fast-
growing phenotype of 51B cells in vivo with quantitative 
data, as shown by images of the xenografts (Figure 3D). 
Interestingly, we observed an increase of RFP copy 
number in 51B-RFP cells in forming the tumor (xenograft) 
compared to its copy number for in vitro cell culture. 
These data suggest that the proliferative potential of cells 
grown in vivo can be distinct from in vitro measurements, 
and that these differential effects can have a significant 
impact on tumorigenicity derived from implanting defined 
mixtures of cells. Both immunofluorescence and H&E 
images of a mouse brain with i.c. xenografts derived from 
Figure 3: Distinct “go” or “grow” features of STIC and TMC from GBM with or without EGFR amplification. (A) 
gelatin zymography of protein precipitated from 48-hour conditioned medium of cell cultures in triplicate. (B) HEMA staining 
of cells in a matrigel invasion assay. The relative invasion rates (SD) are shown below the representative images of invading 
cells, with 51B cell invasion rate set to unity. (C) representative fluorescence image of a mouse brain with i.c. xenografts 
derived from 51A-GFP. (D) a peritumoral region of i.c. xenograft derived from co-implantation of 51A-GFP and 51B-RFP in 
a 9:1 ratio. (E) Kaplan-Meier survival curves of mice with i.c. implantation of 51A infected with a lentiviral vector expressing 
green fluorescence protein (51A-GFP) and 51B infected with a lentiviral vector expressing red fluorescence protein (51B-RFP) 
alone and in combinations at various ratios in six groups (5 mice per group). (F) CQ-PCR analysis of DNA samples from 
cells and the right halves of brains of euthanized mice. (G and H) fluorescence and H&E images of a mouse brain with i.c. 
xenografts derived from 51B-RFP. Pictures were taken using 10X (C, G, and H) or 40X (D) lens of a Keyence BZ-X700 
fluorescence microscope with multiple images seemliness stitched into one.
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51B-RFP showed the fast proliferating characteristics of 
51B cells, with solid tumor masses shown in the brain 
(Figures 3G-3H), which was in striking contrast to the 
diffused tumor cell distribution throughout the mouse 
brain of i.c. xenografts derived from 51A-GFP (Figure 
3C). The decreased survival of mice with i.c. xenografts 
derived from 51A100% and mixture of 51A 99% and 51B 
1% can be explained by these mice having their brains 
damaged from the massive growth of solid tumors, which 
were contributed by the tumor mass-forming cells of 51B, 
as shown in Figures 3D and 3F.
Differential cellular bioenergetics and radiation 
resistance
The above characterization of GBM subcultures 
with EGFR amplification showed the presence of stem-
like invasive cells with DM in 51A and fast-growing 
cells without DM in 51B. We then further studied their 
metabolic parameters by subjecting both primary cultures 
to extracellular flux analyses. In exponentially growing 
cultures (low confluence), both basal and ATP-linked 
(oligomycin-sensitive fraction) oxidative phosphorylation 
was significantly higher in 51B than in 51A (Figure 4A, left 
panel). Under slower growth conditions (high confluence), 
basal and ATP-dependent respiration increased in both 
lines, with no significant differences between the two lines 
(Figure 4A, left panel). There was no difference in OCR 
from proton leakage between the two lines at both low and 
high cell confluence (Figure 4A, left panel). Furthermore, 
reserve respiration capacity could not be detected in 51A 
(the 51A cells were very sensitive to FCCP, especially at 
high density, and resulted in the reduced OCR), suggesting 
that the ATP-reserve was exhausted. This was in contrast 
to 51B, where exponentially growing cells exhibited 
significant mitochondrial reserve that dissipated as cultures 
reached confluence. However, glycolytic respiration 
shown by ECAR was significantly higher in 51A versus 
51B, and was not dependent on culture confluence (Figure 
4A, right panel).
Figure 4: Differential cellular bioenergetics of two GBM subpopulations that changed in response to radiation. (A) 
comparison of basal oxygen consumption rate (OCR) and extracellular acidification (ECAR) levels for 51A and 51B using an extracellular 
flux analyzer in two independent experiments. The cells were cultured for 7 days from 20,000 cells per well (left panel) and for 3 days 
from 140,000 cells per well (right panel) in XF24-plates. 51A and 51B cells were monolayer cultures throughout the experiments, in 
each specified culture medium. Oligomycin (a complex V inhibitor), FCCP (an uncoupler), and Rotenone (a complex I inhibitor) were 
injected sequentially to assay the mitochondrial respiration capacity. The basal respiration, ATP-linked respiration (oligomycin-sensitive 
fraction), proton leak (oligomycin-insensitive fraction), mitochondrial reserve (spared respiration), basal glycolytic respiration and reserved 
glycolytic respiration are compared. Error bars correspond to the SEM of measurements. (B) comparison of OCAR and ECAR levels 
between irradiated 51A and 51B cells, 7 or 11 days post-acute (single dose of 2Gy, low cell density) or chronic (1Gy to 51A or 0.5 Gy to 
51B per day for 10 consecutive days, high cell density) IR, respectively. (C and D) comparison of OCAR and ECAR levels in irradiated 
and un-irradiated cells, with the latter set to unity.
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Similar studies were then conducted to determine 
the impact of acute (2 Gy) or chronic (10 x 0.5 Gy or 
10 x 1.0 Gy) IR on cellular bioenergetics 7 or 11 days 
following exposure, respectively. Following IR, glycolytic 
respiration and oxidative phosphorylation levels remained 
higher and lower, respectively, in 51A compared to 51B 
(Figure 4B), as was the case prior to radiation (Figure 
4A). Further analysis showed that 1 week after 2-Gy 
radiation, basal and ATP-dependent mitochondrial 
respiration was increased and basal glycolytic respiration 
significantly decreased in 51A cells, while no changes 
were found in 51B cells (Figure 4C-4D). However, 
chronic IR compromised both basal and ATP-dependent 
mitochondrial respiration with decreased proton flux in 
both 51A and 51B cultures (Figure 4C). Both acute and 
chronic radiation of 51A caused a reduction of glycolytic 
respiration, but not for 51B (Figure 4D).
The difference in cellular bioenergetics of 51A, 
with a higher glycolytic respiration and lower oxidative 
phosphorylation compared to 51B, and the versatility in 
switching between two respiration systems upon radiation, 
suggested that 51A was more radio-resistant. Since 
51B cells cannot form a colony either under adherent 
conditions or in soft agar, we determined the relative 
radiosensitivity of 51A and 51B by measurements of cell 
proliferation conducted 1 week after two weekly exposures 
(5 Gy each), and comparing to corresponding cells (seeded 
in half amount) without IR. Trypan Blue dye was added 
to trypsin-EDTA during the process of dissociating cells, 
followed by adding 10% serum to inhibit cell digestion. 
The blue-stained cells were considered to be inviable 
cells from IR as they lacked the ability to exclude Trypan 
Blue dye, and were excluded in cell counting. When 
normalized against un-irradiated controls, the surviving 
fraction of 51A was nearly twice that of 51B (Figure 5A). 
In this approach to determining the surviving fraction and 
comparing the two lines of cells, the surviving fraction 
of the slow-growing line may be underestimated in 
comparison to that of the fast-growing line. Since it is the 
slow-growing 51A cells (Figure 5B) that showed a higher 
surviving fraction in comparison of 51B, 51A cells were 
more resistant to IR than 51B cells.
We then carried out a study of the radiation effect 
on molecular changes measured by gelatin zymography 
and AqRT-PCR, and on redox status by fluorescence 
activated cell sorting. In our previous study of radiation 
effects on glioma cells, we found that the extracellular 
level of MMP2 was upregulated by radiation [5]. Here, 
again we found that the high-MMP2-expressing cells of 
51B had increased MMP2 1-3 weeks following both acute 
and chronic IR. In contrast, low-MMP2-expressing cells 
of 51A did not show this effect (Figure 5C).
We compared the redox status of cells in response 
to IR. As shown in Figure 5D (left panel), after acute 
radiation at various dosages, ROS levels were unchanged 
in 51B, while 51A showed a dose-dependent increase. 
Following 10-days of chronic radiation and 10-14 days 
recovery, the ROS and RNS levels were not significantly 
different from that of unirradiated cells (Figure 5E, right 
panel), however, mitochondrial superoxide (MS) remained 
significantly elevated in irradiated cells of 51A and 51B, 
1-2 weeks post-acute or chronic IR (Figure 5D, right 
panel).
A fractionated IR was performed using 51A (3 or 5 
x106/T75 flasks for control or 1 Gy x 10 days, respectively) 
and 51B (2 or 7 x 105/T75 flasks for control or 0.5 Gy x 
10 days, respectively). RNA samples were extracted 11 
days post IR from 4-day cultured cells (1 x 105/well in 
triplicate in 12-well plates). AqRT-PCR showed only a few 
(3 of 36) genes in 51B had altered expression (all being 
downregulated) 11 days after chronic IR (0.5 Gy per day 
for 10 days), among which, two (POU3F2 and SOD1) 
were also downregulated in irradiated 51A (Figure 5E). 
In contrast, chronic IR of 51A at a higher dose (1 Gy per 
day for 10 days) caused upregulation of six genes (MMP2, 
EFEMP1, ANGPT1, ANGPT2, NRP1, and BIRC3) which 
were highly expressed in 51B (Figure 2B) and functionally 
characterized to promote angiogenesis. Other radiation-
upregulated genes in 51A were consistent with its radio-
resistance (BIRC3, GPX4, CHI3L1, and NANOG) and high 
invasiveness (AGAP2 and RHOC).
A repeat of the IR experiment was performed 
using 51A with lower seeding density (8 or 12 x 105/
T75 flasks for control or 1 Gy x 10 days, respectively). 
Large numbers of neurospheres were observed during IR 
treatment. Nine days post IR, cells were plated in a 24-
well plate (1 X105/well in triplicate) and RNA samples 
were extracted one day later. As shown in Figure 5F, 
AqRT-PCR confirmed that most of the genes (BIRC3, 
ANGPT1, NRP1, CHI3L1, EFEMP1, AGAP2, and RHOC) 
had IR-induced up-regulation. Overall, the data from two 
independent IR experiments showed a radiation-regulated 
gene-expression switch of cells with DM to that expressed 
by cells without DM.
Prolonged radiation effect on the tumor 
microenvironment supporting tumor 
recolonization
The data above showed the differential radiation-
resistance and molecular profiles of two subpopulations 
with and without DM, and that the surviving cells with 
DM frequently mis-segregated their DM chromosomes 
to re-populate the population subset of cells lacking DM 
(see study on 51AS7 in Figure 1D) with a corresponding 
change in their molecular phenotype. This suggests 
that cells with DM are largely responsible for tumor 
recurrence. Hence, we carried out a study to determine the 
prolonged paracrine effects of irradiated cells with DM on 
the progeny of cells that survived IR.
We cultured cells from 51A and 51B after chronic 
radiation in basal medium for 1 and 2 days and used 
conditioned medium (CM) to culture un-irradiated cells 
of both types, adding the supplements required by NS and 
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Figure 5: Differential radiation sensitivity and changes of molecular profiles of irradiated GBM subpopulation cells 
with and without DM, but with common and prolonged increase of mitochondrial superoxide. (A) survival fraction of 
cells determined by counting cells not stained by Trypan Blue dye, 1 week after consecutive weekly fractions of the 5-Gy radiation. (B) cell 
doubling time based on the un-irradiated control cells. (C) gelatin zymography gels demonstrating persistent increase of MMP2 by 51B, 
but not 51A, in response to radiation. (D) comparison of reactive oxygen (ROS), and nitrogen (RNS) species and mitochondrial superoxide 
(MS) levels measured by fluorescence activated cell sorting of cells loaded with CMH2DCFDA, DAF, and MitoSOX, respectively, 7-14 
days after acute and chronic IRs. All values were normalized to un-irradiated controls, which were set to unity. Error bars represent SEM 
derived from 4 replicates. (E-F) comparison of gene expressions, quantified by real-time qRT-PCR, in cells from two independent radiation 
experiments.
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SA-lines (EGF/bFGF/B27 for 51A and 10% fetal bovine 
serum for 51B) for five days, followed by cell invasion 
assays and quantification of genes which expressions were 
regulated by radiation. As shown in Figure 6A (upper 
panel), radiation altered the components in CM of cells 
with DM (51A, 51AS7) to promote invasiveness of both 
cells with or without DM in 51A or 51B, respectively. 
However, the direct IR of cells failed to promote, or even 
decreased, cell invasion, likely due to radiation-induced 
cellular damage (Figure 6A bottom panel).
Two marker genes (PAX6, ANGPT1) of 51B were 
upregulated in 51A due to exposure to CM from irradiated 
51A, but not of 51B (Figure 6B). SOD1 and NRP1 were 
respectively up-, and down-regulated in 51A due to 
exposure to CM from irradiated 51B, not of 51A, which 
interestingly, were oppositely affected by IR (Figure 5D). 
IR had both direct and indirect effects on 51B cells to 
increase extracellular activated MMP2 (Figures 5C and 
6C), but not on MMP2 gene expression (Figures 5E and 
6B). These data suggest that MMP2-activating protein(s) 
in 51B were up-regulated directly by IR and indirectly by 
paracrine effects from CM derived from irradiated cells.
A repeat of the IR experiment was performed for 
51A and 51B with seeding density (3 or 6 x 106/T75 flasks 
for control or above described IR, respectively). One day 
post IR, cells were plated in 60 mm dishes (5 x 105/dish), 
then, 10 days post IR, whole-cell lysates were extracted 
from the cells. Consistent with RNA-based analysis 
from the above described IR experiments, protein data 
shown in Figure 7A confirmed IR-induction of EFEMP1 
and AGAP2 in 51A. Immunoblot of 51A showed a 
reduction of 50% of ANGTP2 by IR, while RNA-based 
analysis showed contradictory effects of IR on ANGTP2 
RNA (Figure 5E and 5F). Validation of IR-increased 
expression of ANGTP1 and CHI3L1 at the protein level 
failed due to a lack of specificity of the antibodies when 
applied against these proteins. Consistent with RNA data 
showing ne effect of IR on these gene in 51B, none of 
the IR-regulated protein alterations in 51A were shown 
in 51B. Results from immunoblotting shown in Figure 
Figure 6: Long-lasting effect from irradiated glioma cells in changing their tumor microenvironment to that essential 
for tumor angiogenesis and recolonization. (A) matrigel invasion assay of 51A, 51B, and 51AS7 cells 1 week post radiation 
(bottom panel) or cultured for 5 days in conditioned medium (CM) of each irradiated line (upper panel). The CM was supplemented with 
EGF/bFGF/B27 or FBS to culture 51A or 51B, respectively, in monolayer condition. The controls are the cells in experiments without IR. 
Radiation treatment was as follows: the cells were plated at double the number of the control and exposed to consecutive daily IR of 0.5-Gy 
for 11 days for 51B or 1-Gy for 10 days for 51A and 51AS7. (B) real-time qRT-PCR detected changes in gene expressions 4 days following 
a 5-day culture in conditioned medium from irradiated cells. (C) gelatin zymography assay detected changes in the active level of MMP2 
in 2-day conditioned medium of 51B treated by conditioned medium of irradiated cells for 5 days.
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7A confirmed much higher levels of NOTCH1 and GFAP 
in 51A compared to that of 51B, as shown in Figure 
2A. Different from prior protein analysis with 51A, this 
protein assay showed much lower expression of ACTB 
compared to that of 51B. Reduction in ACTB expression 
by STIC cells in 51A could be caused by longer culturing 
in fibronectin-adherent conditions. The higher levels of 
PAX6 and EFEMP1 in 51B shown in Figure 7A were 
consistent with prior protein and RNA analyses shown in 
Figure 2. None of these highly expressed proteins in 51A 
or 51B were altered by IR.
Using VIVA-20 (30k MWCO PES), equal volumes 
of 2-day conditioned medium (CM) from 51A and 51B 
cell cultures (the same amount of cells seeded 1 day post 
IR and cultured for 9 days), were concentrated 20 fold. 
Protein measurement showed a nearly 10-fold higher 
concentration of protein in CM (CM-P) of 51A compared 
to that of 51B. Immunoblotting of CM-P with antibody 
against ANGTP1 failed to detect ANGTP1, as shown of 
WCL, while SPARC antibody detected SPARC made 
by 51B cells, which were not altered by IR (Figure 7A), 
confirming the RNA analysis shown in Figure 2C.
DISCUSSION
Nearly 40% of GBM tumors demonstrate EGFR 
amplification, mostly associated with DM chromosomes. 
Loss of DM in GBM primary cultures grown under SA 
conditions (adherent conditions in medium containing 
serum) has been longly noticed [12]. Under reported 
neurosphere culture conditions, highly invasive glioma 
cells with amplification of wild-type EGFR have been 
Figure 7: Key molecular and metabolic differences between the DM and no DM subpopulations and their response to 
IR. (A) immunoblots of whole-cell lysate or conditioned-medium protein (CM-P, 30 μg for 51A, 3 μg for 51B) of cells with or without 
IR. AKT was used to control equal protein loading of WCL. Densitometry (carried out using Image J) values are shown below each blot 
after comparison to un-irradiated control. (B) depiction of a model of GBM with EGFR amplification and potential mechanism underlying 
tumor recurrence after radiotherapy. Key cellular respiration machinery and overexpressed genes and hyper activated signaling pathway are 
shown for two cell subpopulations. Validated gene overexpression at the protein level is shown in bold face. MMP2 is based on enzymatic 
activity. This model summarizes the overall data showing that GBM cells with EGFR-carrying DM are stem-like tumor initiating cells 
(STICs) that are invasive and radio-resistant. Surviving cells with DM after radiotherapy give rise to cells without DM, which form the 
tumor mass of a recurrent tumor resembling the original tumor in DM-heterogeneity. IR has a prolonged effect on STIC in promoting its 
invasiveness and conversion to TMC with a pro-angiogenic tumor microenvironment that supports the growth of TMC.
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observed [13]. However, a pair-wise comparison of cell 
subpopulations with, or without EGFR amplification, 
for their differential role in tumor formation and tumor 
recurrence post-IR is currently lacking. Using syngeneic 
GBM cell lines with and without DM, we have shown 
an invasive phenotype of cells with DM, that are likely 
a source of tumor recurrence due to their metabolic 
radioresistance and regenerative plasticity that promotes 
subsequent restoration of tumor heterogeneity by eliciting 
subpopulations of cells lacking DM.
Radiation-induced oxidative stress has been 
shown to alter cell survival parameters through 
metabolic disruptions that alter the redox state and basal 
homeostasis of cells. Past work and current results show 
the capability of acute radiation exposure to elicit an 
acute and protracted oxidative stress in a variety of neural 
cell types. Such temporal kinetics of radiation-induced 
oxidative stress in neural stem and progenitor cells 
showed similarities with that found in irradiated GBM 
cells with DM, with a prolonged effect on the elevation 
of reactive oxygen (ROS) and nitrogen (RNS) species 
in response to acute radiation. Different alterations 
on redox status were seen in glioma cells without DM 
in 51B in which ROS level was stable after acute IR. 
ROS-regulating gene GPX4 was upregulated in 51A but 
unchanged in 51B following IR. This may be related to 
the increase of ROS level in 51A, whereas there was 
no change of ROS in 51B in response to IR. The down-
regulation of SOD1 in both 51A and 51B was consistent 
with their common increase of mitochondrial superoxide 
(MS) levels after radiation.
It has been observed repeatedly, and for a number 
of different GBMs, that STIC and TMC subpopulations 
had different levels of survival after radiation, and that 
the radio-resistant cell subpopulation was more prone 
to changes in its respiration machinery [14, 15]. Here 
we observed again such a phenomenon. After acute 
IR, metabolism of cells with DM in 51A showed an 
increase of oxidative phosphorylation and a decrease of 
glycolysis, while cells without DM in 51B were stable. 
Furthermore, our findings indicate that the radiation-
resistant DM-containing subpopulation possesses the 
ability to survive and ultimately reestablish the original 
tumor heterogeneity necessary for GBM virulence. This 
study has also revealed, for the first time, a paracrine 
effect of irradiated STIC on un-irradiated, newly formed 
STIC and TMC, thereby enhancing tumor development/
regrowth by promoting cell invasion and angiogenesis. 
As shown in Figures 5 and 7, radiation downregulated 
the stem-like cell marker genes while upregulating pro-
invasive (AGAP2, EFEMP1, RHOC) and pro-angiogenic 
(ANGTP1, NRP1) genes/proteins in 51A cells. The 
increase of extracellular active MMP2 by 51B cells, 
directly from IR or indirectly from radiated 51A cells, 
will altered their microenvironment to support growth of 
recurrent tumors post-IR.
MMP2, the key matrix metallopeptidase gene 
overexpressed in high grade glioma functions in promoting 
glioma cell invasion [16–19]. However, MMP2 expression 
level has no prognostic value for GBM (median survival 
of 0.8 year), while having favorable prognostic values for 
grade III anaplastic astracytoma (median survival of 3 
years), anaplastic oligodendroglioma (median survival 7 
years), and grade II oligodendroglioma (median survival 
9-10 years) [20]. For the well-known pro-invasive role 
of MMP2 in cancer, its favorable prognostic effect in 
low-median grades of glioma may be related to a better 
survival of glioma with more invasive tumor cells than that 
with more proliferative tumor cells. GBM is composed 
of both highly invasive and proliferative tumor cells. By 
degradation of the extracellular matrix, a high activity level 
of MMP2 in GBM may support both tumor invasion and 
growth. Here, in a heterogeneous GBM having cell types 
with and without EGFR-encoding DM chromosomes, the 
high MMP2-expressing cell without DM showed high 
in vitro and in vivo cell proliferation, while the low MMP2-
expressing cell with DM showed high invasiveness in both 
in vitro and in vivo conditions. Radiation further increased 
the extracellular level of MMP2 by cells without DM. 
Further study is needed to identify the pro-invasive protein 
in cells with DM and the contribution of MMP2 to overall 
tumor growth and angiogenesis in cells without DM.
In these GBM-derived syngeneic primary cultures, 
the expression of ANGPT1 was upregulated directly and 
indirectly by radiation exposure in the STIC with DM 
subpopulations. ANGPT1 encodes a secreted glycoprotein 
that belongs to the angiopoietin family and plays an 
important role in tumor vascularization as an agonist 
of angiogenic receptor TEK. In fact, inhibitors of this 
interaction have been developed as anti-cancer agents [21, 
22]. Our finding of ANGPT1 upregulation as a prolonged 
response to chronic radiation in the highly infiltrative and 
radio-resistant STIC (with DM) subpopulation of GBM 
supports the rationale of using an inhibitor of ANGPT1/
TEK following radiotherapy to suppress angiogenesis, and 
hinder the development of recurrent GBM.
GBM is heterogeneous for cell types, both at the 
inter-tumoral and intra-tumoral level. That means one 
GBM is different from another GBM. For better treatment 
selection, although unfortunately none of the current 
frontline therapies are effective, GBM can now be classified 
into four subtypes, based on certain alterations of genes and 
gene expressions [1]. It is important to characterize intra-
tumoral heterogeneity of GBM to understand its recurrence 
after therapeutic intervention. However, there are limited 
models thus far to study the mechanisms underlying the 
maintenance of tumor heterogeneity. Here we provide one 
for GBM with EGFR amplification, and the approach for 
further investigation with clinical materials from other 
GBMs with EGFR amplification.
The purpose of using different culture conditions, 
here SA and NS culture conditions, in the establishment 
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of the initial primary cultures from clinical GBM samples 
is to enrich two major tumor cell subpopulations that 
are dependent on different supplementation in the 
culture medium. Further subculture of each SA and NS 
primary culture is to study the ability of different cell 
subpopulations to restore heterogeneity, i.e., to give rise to 
the other cell lineage in each subculture. Using a soft agar-
mediated clonal sub-culturing approach to study restoration 
of tumor heterogeneity is based on our observation that one 
type of cancer cell gives rise to progeny cells of different 
phenotypes under conditions lacking a threshold cue from 
its neighboring cells, by mis-segregation of the tumor-
specific chromosome (e.g. Chr7) during cell division [6]. 
In this particular GBM, however, tumor heterogeneity is 
not re-established via mis-segregation of Chr7, but rather 
by EGFR-containing DM. Whether other GBMs with 
EGFR amplification engendered by DM have heterogeneity 
restored by mis-segregation of DMs requires a further 
investigation using the approach we present in this study.
Chromosome instability is a hallmark of 
cancer, which has led to the conception of cancer as 
a chromosomal disease [23, 24]. Chromosome mis-
segregation is an inheritable source of diversity in tumor 
cell populations, which leads to the successful evolution 
of the cancer and the recurrence of cancer. The GBM 
we studied, yielding the results presented in this paper, 
provide the approach for further investigation with clinical 
materials from other GBMs with EGFR amplification. 
We have shown that all clonal NS-subculture lines with 
(51AS7) or without (51AS3 and 51AS5) DM showed the 
same protein profile (PAX6low/EGFR-PTEN-NOTCHhigh) 
as their parental NS-culture line 51A with DM. It appears 
to be important to this GBM to maintain the tumor 
subpopulation with EGFR overexpression, manifested 
via DM or a mechanism of EGFR up-regulation. Whether 
the high level of EGFR manifested via DM and/or the 
mechanism of EGFR up-regulation is a marker, and/
or causes the observed radio-resistant, invasive and 
angiogenic phenotype, requires further study.
MATERIALS AND METHODS
Ethics statement
The use of fresh GBM tissue and animal in this 
study has been approved by our institutional review board. 
Methods of i.c. cell implantation, survival data and sample 
collection have been described previously [6].
Syngeneic GBM primary cultures, mutation 
assays, and lentivirus infection
Fresh GBM tissue (G43) was dissociated 
enzymatically (0.05% trypsin-EDTA for 30–45 min at 
Table 1: The genetic profile for 51A, 51AS7, 51B, 51A-GFP, 51B-RFP cell lines derived from a recurrent GBM in a 
61-year-old Caucasian female
Marker 51A (p5) 51B (p18) 51AS7 (p4) 51A-GFP (p1) 51B-RFP (p3)
AMEL X X X X X
CSF1PO 10, 12 10, 12 10, 12 10, 12 10, 12
D13S317 11, 12 11, 12 11, 12 11, 12 11, 12
D16S539 11, 13 11, 13 11, 13 11, 13 11, 13
D18S51 12, 15 12, 15 12, 15 12, 15 12, 15
D21S11 29 29 29 29 29
D3S1358 13, 15 13, 15 13, 15 13, 15 13, 15
D5S818 10, 11 10, 11 10, 11 10, 11 10, 11
D7S820 9 9 9 9 9
D8S1179 14 14 14 14 14
FGA 20 20 20 20 20
Penta D 11, 12 11, 12 11, 12 11, 12 11, 12
Penta E 5, 10 5, 10 5, 10 5, 10 5, 10
TH01 8, 9 8, 9 8, 9 8, 9 8, 9
TPOX 8 8 8 8 8
vWA 14 14 14 14 14
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37°C), disrupted mechanically (passing through a glass 
pipette in DMEM/F12 containing 0.10 mg/ml DNase and 
10% serum), and cultured in both collagen-coated (3-4 μg/
cm2) culture dishes in DMEM/F12 supplemented with 10% 
fetal bovine serum, designated as serum adherent (SA) 
culture conditions, and agar (1%)-coated culture dishes in 
DMEM/F12 supplemented with epidermal growth factor 
(EGF, 20 ng/ml), basic fibroblast growth factor (FGF, 10 
ng/ml), and 5% B27 (Invitrogen, Carlsbad, CA), designated 
as neural sphere (NS) culture conditions. Monolayer NS 
culture was achieved by plating single cells dissociated from 
neural spheres using 0.05% trypsin-EDTA into fibronectin 
(1 μg/cm2)-coated dishes in the same culture medium. 
Each passage of an NS-culture was achieved by passing 
through monolayer culture. All cells were maintained at 
37°C with 5% CO2. Cell line authentication for the 51A, 
51AS7, and 51B cell lines was performed by IDEXX 
BioResearch (Columbia, MO). The short tandem repeat 
(STR) profile was identical for all three cell lines confirming 
they originated from the same tumor. The genetic profile 
established for the cell lines is found in Table 1.
For identification of the TP53 mutation, glioma 
cDNA samples were PCR amplified using forward 
primer (5’-GAACAATGGTTCACTGAAGACC-3’) 
annealing to exon 4, and reverse primer 
(5’-AGCTCTCGGAACATCTCGAAG-3’) 
annealing to exon 10 of TP53. For identification 
of the PTEN mutation, nested PCR with forward 
primer (5’- TTCCATCCTGCAGAAGAAGC 
3’) annealing to exon 1, and reverse primer (5’- 
CCATTTTCAGTTTATTCAAGTTTA -3’) annealing 
to exon 9 of PTEN, was based on an initial PCR 
using glioma cDNA samples with primers of 
5’- AAGCAGGCCCAGTCGCTGCA 3’ and 5’- 
GGTCAGGAAAAGAGAATTGTTC -3’. For 
identification of the IDH1 or IDH2 mutation, glioma 
DNA samples were PCR amplified by forward 
primer (5’-CAAGCTATGATTTAGGCATAGAG-3’) 
annealing to the boundary of intron 3 and exon 4, and 
reverse primer (5’-CATGCAAAATCACATTATTGCC 
-3’) annealing to intron 4 of IDH1, or by forward 
primer (5’-GGGACCACTATTATCTCTGTCC-3’) 
annealing to intron 3, and reverse primer 
(5’-GGCCTTGTACTGCAGAGACAAG-3’) annealing 
to intron 4 of IDH2. The annealing temperature for PCR 
was 58°C for all four studied genes, while extension time at 
72°C varied, depending on the size of amplicon; 1 min for 
TP53 (881 bp); 1.5 min for PTEN (1548 in 1st PCR, 1356 
bp in 2nd PCR); 0.5 min for IDH1 (330 bp) and IDH2 (282 
bp). PCR products were purified from single bands cut from 
an agarose gel, extracted using a Gel DNA Recovery Kit 
(Zymo, Research, Irvine, CA), and sequenced by Genewiz 
(South Plainfield, NJ) using forward and/or reverse PCR 
primers of each gene. Pairwise sequence alignment was 
performed using BLAST to compare the wild-type sequence 
with the sequence of PCR samples to identify mutations.
Infectious lentivirus was produced by co-transfection 
of the lentiviral vector plasmid pGIPZ-Empty and pTRIPZ-
Empty (Open Biosystems) with packaging plasmid psPAX2 
and envelope plasmid pCMV-VSVG in HEK-293T cells, 
following the manufacturer’s protocol. Two days after co-
transfection, culture medium containing lentivirus was 
filtered (0.45 μm) and applied to glioma cell cultures. The 
infected glioma cells were selected for 1-2 weeks in culture 
medium containing puromycin (1.25 μg/ml) and examined 
under a fluorescence microscope, which verified expression 
of GFP by 51A infected with pGIPZ-Empty and RFP by 
51B infected with pTRIPZ-Empty 1 day after addition of 
doxycycline (1 μg/ml) to the culture medium.
Soft agar colony formation
5000 cells were mixed with 1 ml of 0.3% SeaPlaque 
GTG Agarose (Lonza, NJ) diluted from autoclaved, 5% of 
agarose in PBS with DMEM/F12 supplemented with 10% 
fetal bovine serum for 51B or a mitogen supplement as 
detailed above for 51A, spread onto hardened 0.5% soft 
agar in the same medium (1 ml per well in four corner 
wells of a 6-well plate). 1 ml of the same medium was 
added 2 and 3 weeks later and after an additional 4-5 
weeks the colonies were counted under a microscope with 
a 4X lens.
Fluorescence in situ hybridization (FISH)
FISH was performed on metaphase spreads using 
Direct Labeled Fluorescent DNA Probe Kits with CEP X/
CEPY, EGFR/CEP 7 (Abbott Molecular Inc. Des Plaines, 
IL) described previously [6]. 250-300 cells per sample were 
counted under a fluorescent microscope with a 100X lens.
Immunoblotting, gelatin zymography, and 
matrigel invasion assays
Primary antibodies for EGFR (rabbit, Cell 
Signaling), NOTCH1 (rabbit, Cell Signaling), AKT 
(rabbit, Cell Signaling), PAX6 (rabbit, COVANCE), PTEN 
(A2B1, mouse, Santa Cruz), NES (mouse, EMD), Gamma 
Secretase (Ab kit for NCSTN), PSEN1 (rabbit, Cell 
Signaling), SPARC (mouse, Santa Cruz), AGAP2 (rabbit, 
Abnova), ANGTP1 (rabbit, Abnova), ANGTP2 (mouse, 
Abnova), CHIL31 (rabbit, Abnova), and EFEMP1 (rabbit, 
Abnova) were diluted 1:500 or 1000, and for GFAP (C-19, 
rabbit, Dako) and ACTB (IgM-specific mouse, Millipore) 
were diluted 1:10,000 for immunoblotting as described 
previously [11].
Gelatin zymography and matrigel invasion 
assays were performed following procedures described 
previously [11]. For the invasion assay in this study, 5×105 
cells in 500 μl DMEM/F12 were loaded in 2-3 replications 
on Matrigel (1 μg/ml)-coated trans-well in 12-well plates 
(8μm; Fisher Scientific), and 1 ml DMEM/F12 was added 
to the bottom chamber. For 51B, addition of a small 
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amount of bovine serum (final 0.05%) in the medium of 
the bottom chamber was applied to enhance migration 
of cells in penetration through the transwell-filter after 
degrading the matrigel, but not to interfere cell-mediated 
matrix degradation by proteases within serum. Images of 
invasion were taken 48 hours later and cells were counted.
Real-time absolute quantitative reverse 
transcription (AqRT-) PCR and comparative 
quantitative polymerase chain reaction (CQ-
PCR)
Total RNA and genomic DNA samples were 
extracted from glioma cell cultures and mouse brains 
carrying glioma xenografts using MiniPrep kits from Zymo 
Research (Irvine, CA). The cDNA samples were converted 
from 1-3 μg RNA using Superscript III reverse transcriptase 
(Invitrogen), diluted more than 20 times with 10 mM Tris. 
HCl (pH7.5), then used (4 μl/each reaction) in real-time 
PCR, with SYBR Green I master mix (Roche). Gene 
expressions were quantified by the AqRT-PCR method 
[10]. DNA copy number variations were measured by CQ-
PCR [25]. AqRT-PCR and CQ-PCR standards and primer 
mixes were provided by Ziren Rsearch LLC (Irvine, CA).
Flux analysis on cellular bioenergetics
To measure respiration and mitochondrial function 
in glioma cells, we employed a Seahorse Bioscience 
XF24 Extracellular Flux Analyzer (Seahorse Bioscience, 
North Billerica, MA), and utilized sequential injections 
of Oligomycin (a complex V inhibitor), FCCP (an 
uncoupler), and Rotenone (a complex I inhibitor), to 
dissect components of oxidative phosphorylation by 
quantification of the oxygen consumption rate (OCR). 
The level of glycolytic respiration was also measured by 
the extracellular acidification rate (ECAR), as described 
previously [4]. Briefly, 51B or 51A cells were respectively 
seeded into a non-coated or fibronectin-coated 24-well 
Seahorse XF-24 assay plates at various plating densities 
and cultured for various days with or without exposure 
to radiation. On the day of metabolic flux analysis, cells 
were washed once with unbuffered DMEM/F12 (pH7.4) 
and incubated at 37°C in the same media in an incubator 
without CO2 for 1 hr. Four baseline measurements of 
OCAR and ECAR were taken before sequential injection of 
the following mitochondrial inhibitors (final concentration): 
oligomycin (1 μg/ml), FCCP (0.3 μM) and rotenone (0.1 
μM). Three measurements were taken after addition of 
each inhibitor. OCR and ECAR values were automatically 
calculated and recorded by the Seahorse XF-24 software. 
The basal respiration was calculated by averaging the four 
measurements of OCR before injection of inhibitors.
Statistical analysis
Overall mouse survivals for different intracranial 
gliomas were analyzed using Weibull regression, a 
parametric survival-regression method, and SAS versions 
9.2 and 9.3 (The SAS Institute, Cary, NC). We used the 
t-test (two tailed) in pairwise comparisons for statistical 
differences.
Abbreviations
FISH: fluorescence in situ hybridization; Chr7: 
chromosome 7; DM: double minute chromosomes; IR: 
irradiation; GBM: glioblastoma multiforme; STIC: stem-
like tumor initiating cell; TMC: tumor mass-forming cell; 
CQ-PCR: comparative quantitative PCR; OCR: oxygen 
consumption rate; ECAR: extracellular acidification rate.
Author contributions
YHZ conceived this study and wrote the paper. 
YHZ, YC, YH, LY, KT, EG, NR, AG, FP, JQ, NA, KCL, 
NL, ERS, MEL, PW, and CL participated in experiments 
and/or data analyses and/or and edited the manuscript.
ACKNOWLEDGMENTS
We thank Dr. John van der Meer for help in editing. 
This work was supported in part by generous gifts from 
Stern Family and the Audley Fund from the Philadelphia 
Foundation (YHZ, MEL) and a grant from HDTRA 1-13-
1-0022 (CL, YHZ, PW).
CONFLICTS OF INTEREST
The authors declare that they have no competing 
interest.
REFERENCES
1. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, 
Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov 
JP, Alexe G, Lawrence M, O’Kelly M, et al, and Cancer 
Genome Atlas Research Network. Integrated genomic 
analysis identifies clinically relevant subtypes of 
glioblastoma characterized by abnormalities in PDGFRA, 
IDH1, EGFR, and NF1. Cancer Cell. 2010; 17:98-110.
2. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici 
G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, 
De Maria R. Tumour vascularization via endothelial 
differentiation of glioblastoma stem-like cells. Nature. 
2010; 468:824-828.
3. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga 
KE, Geber A, Fligelman B, Leversha M, Brennan C, 
Tabar V. Glioblastoma stem-like cells give rise to tumour 
endothelium. Nature. 2010; 468:829-833.
4. Ke C, Tran K, Chen Y, Di Donato AT, Yu L, Hu Y, Linskey 
ME, Wang PH, Limoli CL, Zhou YH. Linking differential 
radiation responses to glioma heterogeneity. Oncotarget. 
2014; 5:1657–65. https://doi.org/10.18632/oncotarget.1823.
Oncotarget80868www.impactjournals.com/oncotarget
5. Baulch JE, Geidzinski E, Tran KK, Yu L, Zhou YH, Limoli 
CL. IR of primary human gliomas triggers dynamic and 
aggressive survival responses involving microvesicle 
signaling. Environ Mol Mutagen. 2016; 57:405-415.
6. Hu Y, Ru N, Xiao H, Chaturbedi A, Hoa NT, Tian XJ, 
Zhang H, Ke C, Yan F, Nelson J, Li Z, Gramer R, Yu L, 
et al. Tumor-specific chromosome mis-segregation controls 
cancer plasticity by maintaining tumor heterogeneity. PLoS 
One. 2013; 8:e80898.
7. Bigner SH, Wong AJ, Mark J, Muhlbaier LH, Kinzler 
KW, Vogelstein B, Bigner DD. Relationship between 
gene amplification and chromosomal deviations in 
malignant human gliomas. Cancer Genet Cytogenet. 1987; 
29:165-170.
8. Brown PD, Krishnan S, Sarkaria JN, Wu W, Jaeckle KA, 
Uhm JH, Geoffroy FJ, Arusell R, Kitange G, Jenkins RB, 
Kugler JW, Morton RF, Rowland KM Jr, et al, and North 
Central Cancer Treatment Group Study N0177. Phase I/II 
trial of erlotinib and temozolomide with radiation therapy in 
the treatment of newly diagnosed glioblastoma multiforme: 
North Central Cancer Treatment Group Study N0177. J Clin 
Oncol. 2008; 26:5603-5609.
9. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, 
Vrionis FD, Steindler DA. Human cortical glial tumors 
contain neural stem-like cells expressing astroglial and 
neuronal markers in vitro. Glia. 2002; 39:193-206.
10. Zhou YH, Raj VR, Siegel E, Yu L. Standardization of Gene 
Expression Quantification by Absolute Real-Time qRT-PCR 
System Using a Single Standard for Marker and Reference 
Genes. Biomark Insights. 2010; 5:79-85.
11. Mayes DA, Hu Y, Teng Y, Siegel E, Wu X, Panda K, Tan 
F, Yung WK, Zhou YH. PAX6 suppresses the invasiveness 
of glioblastoma cells and the expression of the matrix 
metalloproteinase-2 gene. Cancer Res. 2006; 66:9809-9817.
12. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, 
Werner MH, Bigner DD, Bigner SH. Amplification and 
expression of the epidermal growth factor receptor gene in 
human glioma xenografts. Cancer Res. 1988; 48:2231-2238.
13. Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, 
Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO, 
Sakariassen PO, Eskilsson E, Stieber D, Keunen O, Brekka 
N, et al. EGFR wild-type amplification and activation 
promote invasion and development of glioblastoma 
independent of angiogenesis. Acta Neuropathol. 2013; 
125:683-698.
14. Castro-Rivera E, Ran S, Brekken RA, Minna JD. 
Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/
Akt pathway through neuropilin-1 in lung and breast cancer 
cells. Cancer Res. 2008; 68:8295-8303.
15. Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, 
Poulou M, Popescu R, Della Donna L, Evers P, Dekmezian 
C, Reue K, Christofk H, Mischel PS, Pajonk F. Metabolic 
state of glioma stem cells and nontumorigenic cells. Proc 
Natl Acad Sci U S A. 2011; 108:16062-16067.
16. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto 
E, Seiki M. A matrix metalloproteinase expressed on the 
surface of invasive tumour cells. Nature. 1994; 370:61-65.
17. Noel A, Gilles C, Bajou K, Devy L, Kebers F, Lewalle JM, 
Maquoi E, Munaut C, Remacle A, Foidart JM. Emerging 
roles for proteinases in cancer. Invasion Metastasis. 1997; 
17:221-239.
18. McCawley LJ, Matrisian LM. Tumor progression: defining 
the soil round the tumor seed. Curr Biol. 2001; 11:R25-27.
19. Zhou YH, Hess KR, Liu L, Linskey ME, Yung WK. 
Modeling prognosis for patients with malignant astrocytic 
gliomas: quantifying the expression of multiple genetic 
markers and clinical variables. Neuro-oncol. 2005; 
7:485-494.
20. Zhou YH, Hess KR, Raj VR, Yu L, Liu L, Yung AW, 
Linskey ME. Establishment of prognostic models 
for astrocytic and oligodendroglial brain tumors with 
standardized quantification of marker gene expression and 
clinical variables. Biomark Insights. 2010; 5:153-168.
21. Coxon A, Bready J, Min H, Kaufman S, Leal J, Yu D, Lee 
TA, Sun JR, Estrada J, Bolon B, McCabe J, Wang L, Rex 
K, et al. Context-dependent role of angiopoietin-1 inhibition 
in the suppression of angiogenesis and tumor growth: 
implications for AMG 386, an angiopoietin-1/2-neutralizing 
peptibody. Mol Cancer Ther. 2010; 9:2641-2651.
22. Falcon BL, Hashizume H, Koumoutsakos P, Chou J, Bready 
JV, Coxon A, Oliner JD, McDonald DM. Contrasting 
actions of selective inhibitors of angiopoietin-1 and 
angiopoietin-2 on the normalization of tumor blood vessels. 
Am J Pathol. 2009; 175:2159-2170.
23. Duesberg P, Stindl R, Hehlmann R. Origin of multidrug 
resistance in cells with and without multidrug resistance 
genes: chromosome reassortments catalyzed by aneuploidy. 
Proc Natl Acad Sci U S A. 2001; 98:11283-11288.
24. Lee AJ, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ, 
Futreal PA, Downward J, Szallasi Z, Tomlinson IP, Howell 
M, Kschischo M, Swanton C. Chromosomal instability 
confers intrinsic multidrug resistance. Cancer Res. 2011; 
71:1858-1870.
25. Chaturbedi A, Yu L, Linskey ME, Zhou YH. Detection of 
1p19q deletion by real-time comparative quantitative PCR. 
Biomark Insights. 2012; 7:9-17.
